We hypothesize that TREM-1 mediatesthe activation of its ligands, such as HMGB2, as well as inflammatory cellreceptors (RAGE, TLR-4 and TLR-2), thereby initiating downstream signalingpathways that ultimately lead to AAA. The gene discussed is HMGB2; the disease is triple-A syndrome.